Literature DB >> 7886039

Trypanosoma brucei is protected from the cytostatic effects of nitric oxide under in vivo conditions.

N A Mabbott1, I A Sutherland, J M Sternberg.   

Abstract

In mice infected with Trypanosoma brucei, splenic and peritoneal macrophages release substantial amounts of nitric oxide (NO). The production of NO by activated macrophages has been reported to be a nonspecific immune-effector mechanism against several parasites, and in this work we investigate the role of NO in killing T. brucei. Addition of bloodstream trypanosomes to peritoneal macrophages activated in vitro resulted in an NO-dependent inhibition of parasite growth. This effect was totally abrogated when dilutions of whole blood were included in the cultures, suggesting that bloodstream parasites such as T. brucei are not susceptible to NO-mediated killing in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7886039     DOI: 10.1007/bf00932954

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  23 in total

1.  Antigenic variation in syringe passaged populations of Trypanosoma (Trypanozoon) brucei. 1. Rationalization of the experimental approach.

Authors:  N Van Meirvenne; P G Janssens; E Magnus
Journal:  Ann Soc Belg Med Trop       Date:  1975

Review 2.  Biosynthesis and metabolism of endothelium-derived nitric oxide.

Authors:  L J Ignarro
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

3.  Antigenic variation in clones of animal-infective Trypanosoma brucei derived and maintained in vitro.

Authors:  J J Doyle; H Hirumi; K Hirumi; E N Lupton; G A Cross
Journal:  Parasitology       Date:  1980-04       Impact factor: 3.234

4.  Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.

Authors:  S L James; J Glaven
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.

Authors:  C D Mills
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

6.  Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity.

Authors:  A Severn; D Xu; J Doyle; L M Leal; C A O'Donnell; S J Brett; D W Moss; F Y Liew
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

7.  Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.

Authors:  L S Anthony; P J Morrissey; F E Nano
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

8.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

9.  Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei.

Authors:  P Vincendeau; S Daulouède; B Veyret; M L Darde; B Bouteille; J L Lemesre
Journal:  Exp Parasitol       Date:  1992-11       Impact factor: 2.011

10.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.

Authors:  J Chan; Y Xing; R S Magliozzo; B R Bloom
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  10 in total

1.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

2.  Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination.

Authors:  P S Coulson; L E Smythies; C Betts; N A Mabbott; J M Sternberg; X G Wei; F Y Liew; R A Wilson
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

3.  Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice.

Authors:  N Mabbott; J Sternberg
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  African trypanosome infections in mice that lack the interferon-gamma receptor gene: nitric oxide-dependent and -independent suppression of T-cell proliferative responses and the development of anaemia.

Authors:  N A Mabbott; P S Coulson; L E Smythies; R A Wilson; J M Sternberg
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

5.  T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase.

Authors:  A E Millar; J Sternberg; C McSharry; X Q Wei; F Y Liew; C M Turner
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Dermal bacterial LPS-stimulation reduces susceptibility to intradermal Trypanosoma brucei infection.

Authors:  Omar A Alfituri; Enock M Mararo; Pieter C Steketee; Liam J Morrison; Neil A Mabbott
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

7.  Trypanosoma congolense Infections: Induced Nitric Oxide Inhibits Parasite Growth In Vivo.

Authors:  Wenfa Lu; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  J Parasitol Res       Date:  2011-04-05

Review 8.  To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host.

Authors:  Omar A Alfituri; Juan F Quintana; Annette MacLeod; Paul Garside; Robert A Benson; James M Brewer; Neil A Mabbott; Liam J Morrison; Paul Capewell
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

9.  Molecular regulation of Trypanosoma congolense-induced nitric oxide production in macrophages.

Authors:  Rani Singh; Bruce C Kone; Abdelilah S Gounni; Jude E Uzonna
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

Review 10.  Host Immune Responses and Immune Evasion Strategies in African Trypanosomiasis.

Authors:  Chukwunonso Onyilagha; Jude Ezeh Uzonna
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.